Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice.

Repertoires of Autophagy in the Pathogenesis of Ocular Diseases

Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351

Autophagy fights disease through cellular self-digestion

Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452

Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator

West, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492

Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease

Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347

Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208

A Century of Alzheimer's Disease

Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,150

The roles of intracellular protein-degradation pathways in neurodegeneration

Rubinsztein, D. C. (2006) · Nature · doi:10.1038/nature05291 · Cited by 1,625

Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's Disease

Boland, B., Kumar, A., Lee, S., Platt, F. M., Wegiel, J., Yu, W. H., & Nixon, R. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0800-08.2008 · Cited by 1,119

Alzheimer's disease: strategies for disease modification

Citron, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2896 · Cited by 1,075

Pharmacological mTOR inhibitors in ameliorating Alzheimer’s disease: current review and perspectives

Xie, P.-L., Zheng, M.-Y., Han, R., Chen, W., & Mao, J.-H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1366061 · Cited by 40

Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation in vitro and in vivo

Schweig, J. E., Yao, H., Coppola, K., Jin, C., Crawford, F., MULLAN, M. J., & Paris, D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008033 · Cited by 38

Activate or Inhibit? Implications of Autophagy Modulation as a Therapeutic Strategy for Alzheimer’s Disease

Krishnan, S., Shrestha, Y., Jayatunga, D. P. W., Rea, S. L., Martins, R. N., & Bharadwaj, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186739 · Cited by 38

Association Between Atg5-independent Alternative Autophagy and Neurodegenerative Diseases

Honda, S., Arakawa, S., Yamaguchi, H., Torii, S., Sakurai, H. T., Tsujioka, M., Murohashi, M., & Shimizu, S. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.016 · Cited by 36

Endolysosome and Autolysosome Dysfunction in Alzheimer’s Disease: Where Intracellular and Extracellular Meet

van Weering, J. R. T., & Scheper, W. (2019) · CNS Drugs · doi:10.1007/s40263-019-00643-1 · Cited by 38

Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms

Hwang, K., Vaknalli, R. N., Addo-Osafo, K., Vicente, M., & Vossel, K. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.903973 · Cited by 35

Lithium and the Interplay Between Telomeres and Mitochondria in Bipolar Disorder

Lundberg, M., Millischer, V., Backlund, L., Martinsson, L., Stenvinkel, P., Sellgren, C. M., Lavebratt, C., & Schalling, M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.586083 · Cited by 38

FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders

Lui, A., Vanleuven, J., Perekopskiy, D., Liu, D., Xu, D., Alzayat, O., Elgokhy, T., Do, T., Gann, M., Martin, R. M., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15121546 · Cited by 36

Differential effects of voluntary treadmill exercise and caloric restriction on tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology fed with Western diet

Gratuze, M., Julien, J., Morin, F., Marette, A., & Planel, E. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.08.001 · Cited by 34

Alzheimer’s disease: phenotypic approaches using disease models and the targeting of tau protein

Lauretti, E., & Praticò, D. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1737012 · Cited by 34

Heavy metal-induced disruption of the autophagy-lysosomal pathway: implications for aging and neurodegenerative disorders

Das, S., Murumulla, L., Ghosh, P., & Challa, S. (2025) · BioMetals · doi:10.1007/s10534-025-00665-x · Cited by 30

Autophagy and lysosomal pathways in nervous system disorders

Bingol, B. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.04.009 · Cited by 32

Autophagy in ageing and ageing-related neurodegenerative diseases

Karabiyik, C., Frake, R. A., Park, S. J., Tanasa, M. P., & Rubinsztein, D. C. (2021) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2021.05 · Cited by 31

Biomedical Implications of Autophagy in Macromolecule Storage Disorders

Palhegyi, A. M., Seranova, E., Dimova, S., Hoque, S., & Sarkar, S. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00179 · Cited by 30

The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome

Zuliani, I., Lanzillotta, C., Tramutola, A., Francioso, A., Pagnotta, S. E., Barone, E., Marzia Perluigi, A., & Domenico, F. D. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00978-4 · Cited by 29

Combining autophagy stimulators and cellulose ethers for therapy against prion disease

Abdulrahman, B., Tahir, W., Doh‐ura, K., Gilch, S., & Schätzl, H. M. (2019) · Prion · doi:10.1080/19336896.2019.1670928 · Cited by 29

Therapeutic Strategies for Restoring Tau HomeostasisPreprint

Young, Z. T., Mok, S., & Gestwicki, J. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024612 · Cited by 31

Synaptic sabotage: How Tau and α-Synuclein undermine synaptic health

Uytterhoeven, V., Verstreken, P., & Nachman, E. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202409104 · Cited by 29

Comparative analysis of autophagy and tauopathy related markers in cerebral ischemia and Alzheimer’s disease animal models

Villamil-Ortiz, J., & Cardona-Gómez, G. P. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00084 · Cited by 29

Alginate-Derived Mannuronate Oligosaccharide Attenuates Tauopathy through Enhancing Autophagy

Bi, D., Xiao, S., Lin, Z., Yao, L., Fang, W., Wu, Y. L., Xu, H. Y., Lu, J., & Xu, X. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c00394 · Cited by 28

Endosomal‐lysosomal dysfunctions in Alzheimer’s disease: Pathogenesis and therapeutic interventions

Lai, S. S. M., Ng, K. Y., Koh, R. Y., Chok, K. C., & Chye, S. M. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00737-0 · Cited by 31

Autophagy Modulation in Aggresome Formation: Emerging Implications and Treatments of Alzheimer’s Disease

Rahman, M. A., Rahman, M. H., Mamun-Or-Rashid, A. N. M., Hwang, H., Chung, S., Kim, B., & Rhim, H. (2022) · Biomedicines · doi:10.3390/biomedicines10051027 · Cited by 31

Increased mitochondrial calcium uptake and concomitant mitochondrial activity by presenilin loss promotes mTORC1 signaling to drive neurodegeneration

Ryan, K. C., Ashkavand, Z., Sarasija, S., Laboy, J. T., Samarakoon, R., & Norman, K. R. (2021) · Aging Cell · doi:10.1111/acel.13472 · Cited by 27

P62 accumulates through neuroanatomical circuits in response to tauopathy propagation

de Thé, F.-X. B., Lassus, B., Schaler, A. W., Fowler, S. L., Goulbourne, C. N., Jeggo, R., la Cour, C. M., Millan, M. J., & Duff, K. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01280-w · Cited by 28

Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease

Cardoso, S., Seiça, R. M. F., & Moreira, P. I. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1205488 · Cited by 27

Neurofibrillary Tangles and Conversion to Mild Cognitive Impairment with Certain Antihypertensives

Wharton, W., Zhao, L., Steenland, K., Goldstein, F. C., Schneider, J. A., Barnes, L. L., Gearing, M., & Yaşar, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190011 · Cited by 28

Syntheses, neural protective activities, and inhibition of glycogen synthase kinase-3β of substituted quinolines

Lu, J., Maezawa, I., Weerasekara, S., Erenler, R., Nguyen, T. D. T., Nguyen, J. T., Swisher, L. Z., Li, J., Jin, L., Ranjan, A., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.05.085 · Cited by 26

Autophagy-targeted therapy to modulate age-related diseases: Success, pitfalls, and new directions

Martins, W. K., Silva, M. N., Pandey, K. R., Maejima, I., Ramalho, E. D. S., Olivon, V. C., Diniz, S. N., & Grasso, D. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100033 · Cited by 27

Multidimensional autophagy nano-regulator boosts Alzheimer's disease treatment by improving both extra/intraneuronal homeostasis

Li, Y., Yang, P., Meng, R., Xu, S., Zhou, L., Qian, K., Wang, P., Cheng, Y., Sheng, D., Xu, M., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.10.009 · Cited by 26

A seeding based cellular assay of tauopathy

Xu, Y., Martini‐Stoica, H., & Zheng, H. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0100-9 · Cited by 26

Hepatic S6K1 Partially Regulates Lifespan of Mice with Mitochondrial Complex I Deficiency

Ito, T. K., Lu, C., Khan, J., Nguyen, Q., Huang, H. Z., Kim, D., Phillips, J., Tan, J., Lee, Y., Nguyen, T., et al. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00113 · Cited by 27

Impaired autophagy in amyloid-beta pathology: A traditional review of recent Alzheimer's research

Yuan, M., Wang, Y., Huang, Z., Jing, F., Qiao, P., Zou, Q., Li, J., & Cai, Z. (2022) · Journal of Biomedical Research · doi:10.7555/jbr.36.20220145 · Cited by 26

The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer’s Disease Type

Pluta, R. M., Czuczwar, S. J., Januszewski, S., & Jabłoński, M. (2021) · Cells · doi:10.3390/cells10092213 · Cited by 24

Mammalian Target of Rapamycin at the Crossroad Between Alzheimer’s Disease and Diabetes

Liang, H., Nie, J., Skike, C. E. V., Valentine, J. M., & Orr, M. E. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_10 · Cited by 24

The use of geroprotectors to prevent multimorbidity: Opportunities and challenges

Morsli, S., & Bellantuono, I. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111391 · Cited by 24

Autophagy in brain tumors: molecular mechanisms, challenges, and therapeutic opportunities

Zhang, J., Jinan, Z., & Chen, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-06063-0 · Cited by 24

Small-molecule drug screening identifies drug Ro 31-8220 that reduces toxic phosphorylated tau in Drosophila melanogaster

Shim, K.-H., Kim, S.-H., Hur, J., Kim, D., Demirev, A. V., & Yoon, S. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104519 · Cited by 23

Altered Proteostasis in Neurodegenerative Tauopathies

Papanikolopoulou, K., & Skoulakis, E. M. C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_7 · Cited by 23

The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases

Jiao, F., Zhou, B., & Meng, L. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13985 · Cited by 21

Severe oligomeric tau toxicity can be reversed without long-term sequelae

Martinisi, A., Flach, M., Sprenger, F., Frank, S., Tolnay, M., & Winkler, D. T. (2020) · Brain · doi:10.1093/brain/awaa445 · Cited by 22

The innate immune response in tauopathies

Johnson, A. M., & Lukens, J. R. (2023) · European Journal of Immunology · doi:10.1002/eji.202250266 · Cited by 22

Genetic enhancement of macroautophagy in vertebrate models of neurodegenerative diseases

Ejlerskov, P., Ashkenazi, A., & Rubinsztein, D. C. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.04.001 · Cited by 20

Human Induced Pluripotent Stem Cell Models of Neurodegenerative Disorders for Studying the Biomedical Implications of Autophagy

Seranova, E., Palhegyi, A. M., Verma, S., Dimova, S., Lasry, R., Naama, M., Sun, C., Barrett, T. G., Rosenstock, T. R., Kumar, D., et al. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.024 · Cited by 20

Exploring the potential role of rab5 protein in endo-lysosomal impairment in Alzheimer’s disease

Behl, T., Kaur, D., Sehgal, A., Singh, S., Makeen, H. A., Albratty, M., Abdellatif, A. A. H., Dachani, S. R., & BUNGAU, S. G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112773 · Cited by 20

Pharmacological mTOR-inhibition facilitates clearance of AD-related tau aggregates in the mouse brain

Morawe, M. P., Liao, F., Amberg, W., van Bergeijk, J., Chang, R., Gulino, M., Hamilton, C., Hoft, C., Lumpkin, C. J., Mastis, B., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175301 · Cited by 20

Autophagy in alzheimer disease pathogenesis and its therapeutic values

Angst, G., Jia, N., Esqueda, L. T., Fan, Y., Cai, Q., & Wang, C. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2471677 · Cited by 22

Bi-Directional Relationship Between Autophagy and Inflammasomes in Neurodegenerative Disorders

Panda, C., & Mahapatra, R. K. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01184-2 · Cited by 20

Repurposing digoxin for geroprotection in patients with frailty and multimorbidity

Lee, H., Wilson, D. V., Bunting, K. V., Kotecha, D., & Jackson, T. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101860 · Cited by 19

Disease-modifying therapies for tauopathies: agents in the pipeline

Panza, F., Imbimbo, B. P., Lozupone, M., Greco, A., Seripa, D., Logroscino, G., Daniele, A., & Colosimo, C. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1606715 · Cited by 20

Molecular Basis of Neuronal Autophagy in Ageing: Insights from Caenorhabditis elegans

Konstantinidis, G., & Tavernarakis, N. (2021) · Cells · doi:10.3390/cells10030694 · Cited by 19

Influence of Tau on Neurotoxicity and Cerebral Vasculature Impairment Associated with Alzheimer’s Disease

Rather, M. A., Khan, A., Jahan, S., Siddiqui, A. J., & Wang, L. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.05.042 · Cited by 18

Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of disease

Zuniga, G., Katsumura, S., Mange, J. D., Ramirez, P., Atrian, F., Morita, M., & Frost, B. E. (2024) · Aging Cell · doi:10.1111/acel.14245 · Cited by 15

Truncated tau interferes with the autophagy and endolysosomal pathway and results in lipid accumulation

Pollack, S. J., Dakkak, D., Guo, T., Chennell, G., Gomez-Suaga, P., Noble, W., Jimenez-Sanchez, M., & Hanger, D. P. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05337-6 · Cited by 14

Novel prospects in targeting neurodegenerative disorders via autophagy

Khan, S., Upadhyay, S., & Hassan, M. I. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177060 · Cited by 15

Effects of Chronic Arginase Inhibition with Norvaline on Tau Pathology and Brain Glucose Metabolism in Alzheimer's Disease Mice

Polis, B., Squillario, M., Gurevich, V., Srikanth, K. D., Assa, M., & Samson, A. O. (2022) · Neurochemical Research · doi:10.1007/s11064-021-03519-3 · Cited by 15

Effect of Nrf2 loss on senescence and cognition of tau-based P301S mice

Riordan, R., Wang, R., Yu, Z., Ross, G., Valerio, J., Dimas-Muñoz, J., Heredia, V., Magnusson, K. R., Galván, V., & Pérez, V. (2023) · GeroScience · doi:10.1007/s11357-023-00760-2 · Cited by 15

Autophagy and exosomes; inter-connected maestros in Alzheimer’s disease

Atya, H. B., Sharaf, N. M., Abdelghany, R. M., El-Helaly, S. N., & Taha, H. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01466-3 · Cited by 14

Disease-modifying strategies in primary tauopathies

Rösler, T. W., Costa, M., & Höglinger, G. U. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107842 · Cited by 16

Dihydrotanshinone I Increase Amyloid-β Clearance and Decrease Tau Phosphorylation via Enhancing Autophagy

Bao, Z., Zhang, H., Jiao, H., Chu, X., Fu, J. X., & Wang, L. (2020) · Pharmacology · doi:10.1159/000503792 · Cited by 14

Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies

Cai, J., Xie, D., Kong, F., Zhai, Z., Zhu, Z., Zhao, Y., Xu, Y., & Sun, T. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231249 · Cited by 13

Unknown roles of tau pathology in neurological disorders. Challenges and new perspectives

Olesen, M. A., Villavicencio-Tejo, F., Cuevas-Espinoza, V., & Quintanilla, R. A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102594 · Cited by 12

Genipin and pyrogallol: Two natural small molecules targeting the modulation of disordered proteins in Alzheimer's disease

Kim, S., Hyun, D. G., Nam, Y., Shin, S. J., Im, D., Kim, H. S., Leem, S. H., Park, H. H., Kim, B., Park, Y., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115770 · Cited by 13

Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets

Chauhan, P., Wadhwa, K., & Singh, G. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156109 · Cited by 12

“Dirty Dancing” of Calcium and Autophagy in Alzheimer’s Disease

Zhang, H., & Борисович, Б. И. (2023) · Life · doi:10.3390/life13051187 · Cited by 11

Shared mechanisms of neural circuit disruption in tuberous sclerosis across lifespan: Bridging neurodevelopmental and neurodegenerative pathology

Litwa, K. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.997461 · Cited by 10

Attenuation of HECT-E3 ligase expression rescued memory deficits in 3xTg-AD mice

Suresh, P., Jasmin, S., Yen, Y., Hsu, H., Varinthra, P., Pairojana, T., Chen, C., & Liu, I. Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.916904 · Cited by 9

Dynamics of microtubules and their associated proteins

Benarroch, E. E. (2016) · Neurology · doi:10.1212/wnl.0000000000002686 · Cited by 9

Molecular targets and approaches to restore autophagy and lysosomal capacity in neurodegenerative disorders

Bastien, J., Menon, S., Messa, M., & Nyfeler, B. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101018 · Cited by 9

Animal Models of Movement Disorders

Duty, S., & Jenner, P. G. (2017) · Springer eBooks · doi:10.1007/978-3-7091-1628-9_2 · Cited by 9

Autophagy–NAD+ axis: emerging insights into neuronal homeostasis and neurodegenerative diseases

Koçak, G., Dimas, M. M., Silva, L., Silva-Amaral, D., Sun, C., Cruddas, S., Barrett, T. G., Martins‐de‐Souza, D., Cunha‐Neto, E., Brocardo, P. S., et al. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1695486 · Cited by 8

Autophagy and Cell Death in Alzheimer’s, Parkinson’s and Prion Diseases

Ribarič, S., & Ribarič, I. M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86706 · Cited by 9

Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: Predictions using an integrated Alzheimer’s Disease Platform

Karelina, T., Lerner, S., Stepanov, A. A., Meerson, M., & Demin, O. O. (2021) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12628 · Cited by 8

The Cascade of Oxidative Stress and Tau Protein Autophagic Dysfunction in Alzheimer’s Disease

Liu, Z., Li, P., Wu, J., Wang, Y., Li, P., Hou, X., Zhang, Q., Wei, N., Zhao, Z., Liang, H., et al. (2015) · InTech eBooks · doi:10.5772/59980 · Cited by 9

Dual mTORC1/mTORC2 blocker as a possible therapy for tauopathy in cellular model

Salama, M., El‐Hussiny, M., Magdy, A., Omran, A. G., Alsayed, A., Ashry, R., & Mohamed, W. M. Y. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0137-7 · Cited by 8

siRNA Blocking of Mammalian Target of Rapamycin (mTOR) Attenuates Pathology in Annonacin-Induced Tauopathy in Mice

Salama, M., El-Desouky, S., Alsayed, A., El‐Hussiny, M., Magdy, K., Fekry, E., Shabka, O., El‐Khodery, S., Youssef, M. A., Sobh, M. A. K., et al. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9974-3 · Cited by 8

A perspective on autophagy and transcription factor EB in Alcohol-Associated Alzheimer’s disease

Zhang, C., Chen, H., Rodriguez, Y., Ma, X., Swerdlow, R. H., Zhang, J., & Ding, W. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115576 · Cited by 8

Autophagy and tau protein

Hamano, T., & Endo, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89906-2.00006-x · Cited by 7

Inhibition of Tau aggregation with BSc3094 reduces Tau and decreases cognitive deficits in rTg4510 mice

Anglada‐Huguet, M., Rodrigues, S., Hochgräfe, K., Mandelkow�, E., & Mandelkow, E. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12170 · Cited by 7

Effects and Mechanisms of Rapamycin Action on Experimental Neurodegeneration

Pupyshev, A. B., Короленко, Т. А., & Tikhonova, M. A. (2018) · Neurochemical Journal · doi:10.1134/s1819712418030108 · Cited by 6

Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024)

Aliashrafzadeh, H., Liu, D., Alba, S. D., Akbar, I., Lui, A., Vanleuven, J., Martin, R. M., Wang, Z., & Liu, D. (2025) · Exploration of Drug Science · doi:10.37349/eds.2025.1008116 · Cited by 5

Axon Injury-Induced Autophagy Activation Is Impaired in a C. elegans Model of Tauopathy

Ko, S. H., Gonzalez, G., Liu, Z., & Chen, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228559 · Cited by 5

Frontotemporal dementia

Wauters, E., Sleegers, K., Cruts, M., & Broeckhoven, C. V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00009-9 · Cited by 6

Autophagy in cancer and protein conformational disorders

Attanasio, S. (2025) · FEBS Letters · doi:10.1002/1873-3468.70061 · Cited by 5

The many connections of UFMylation with Alzheimer’s disease: a comprehensive review

Yan, T., Clarkson, B. D. S., Lou, Z., Springer, W., & Fiesel, F. C. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00855-8 · Cited by 4

Targeting Liquid-Liquid Phase Separation and Autophagy in Alzheimer’s Disease: Insights into Molecular Mechanisms and Therapeutic Potential

Li, X., Liu, Y., Hong, H., & Li, S. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04623-4 · Cited by 4

Effect of rapamycin on repeated immobilization stress-induced immune alterations in the rat spleen

Rokytová, I., Mravec, B., Lauková, M., & Vargovič, P. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577309 · Cited by 4

Pathological conditions associated with tau protein: mechanisms of development and possible biological targets for pharmacological correction of tau proteinopathy (review)

Kuzubova, E. V., Radchenko, A. I., Pokrovsky, V. M., Patrakhanov, E. A., Novikova, A. A., Stepenko, Y. V., & Deykin, A. V. (2022) · RESEARCH RESULTS IN BIOMEDICINE · doi:10.18413/2658-6533-2022-8-4-0-6 · Cited by 4

Calorie Restriction Mimetics: Progress and Potential

Roth, G. S., & Ingram, D. K. (2015) · Healthy ageing and longevity · doi:10.1007/978-3-319-14830-4_10 · Cited by 5

Targeted genome editing of ZKSCAN3 mitigates the neurotoxicity caused by mutant HTT (huntingtin) in a Huntington disease animal model and three-dimensional cell culture of Huntington disease

Park, H. J., Kim, J., Choi, J., Ryou, C., Shin, E., & Lee, J. (2025) · Autophagy · doi:10.1080/15548627.2025.2569965 · Cited by 3

Presenilin-dependent regulation of neuronal tau pathology via the autophagy and proteasome pathways

del Ser‐Badia, A., Soto-Faguás, C. M., Vecino, R., Vendrell, C., Molina‐Porcel, L., Sánchez‐Valle, R., Rodrı́guez-Álvarez, J., Vicario‐Abejón, C., & Saura, C. A. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02270-6 · Cited by 3

Restoration of autophagy-lysosomal function via transcranial focused ultrasound stimulation ameliorates β-amyloid pathology and cognitive deficits in an Alzheimer’s disease model

Wang, M., Zhang, B., Guo, R., Wang, H., Wu, D., Peng, X., Guo, H., Duan, J., Yang, W., Ren, P., et al. (2026) · Ultrasonics · doi:10.1016/j.ultras.2026.108075 · Cited by 3

Stimulation of Tau Degradation

Quintanilla, R. A., Cabezas-Opazo, F., Pallo, S. P., Chesser, A. S., & Johnson, G. V. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00013-7 · Cited by 3

Bridging autophagy and endolysosomal dysfunction: Role of bridging integrator 1 in Alzheimer’s disease

Duckhorn, J. C., Kim, D. K., & Huang, Y. A. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00243 · Cited by 2

Targeting Mitochondria and Redox Dyshomeostasis in Brain Ageing: An Update

Cardoso, S., & Moreira, P. I. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-84965-8_8 · Cited by 2

Frontotemporal lobar degeneration

Kim, B., Viera-Ortiz, A., Phan, J. M., Irwin, D. J., & Lee, E. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00041-1 · Cited by 3

Neurodegenerative Diseases and Autophagy

Fleming, A., Vicinanza, M., Renna, M., Puri, C., Ricketts, T., Füllgrabe, J., López, A., de Jager, S. M., Ashkenazi, A., Tanasa, M. P., et al. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00011-0 · Cited by 2

Increased Mitochondrial Calcium Uptake and Concomitant Hyperactivity by Presenilin Loss Promotes mTORC1 Signaling to Drive NeurodegenerationPreprint

Ryan, K. C., Ashkavand, Z., Sarasija, S., Laboy, J. T., Samarakoon, R., & Norman, K. R. (2020) · Research Square · doi:10.21203/rs.3.rs-120594/v1 · Cited by 2

Autophagy Mechanisms for Brain Recovery. Keep It Clean, Keep It Alive

Nobili, A., Barbera, L. L., Mastrantonio, R., Palazzo, C., Molinari, M., D’Amelio, M., & Viscomi, M. T. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-24930-3_2 · Cited by 1

Stochastic formal model of PI3K/mTOR pathway in Alzheimer's disease for drug repurposing: An evaluation of rapamycin, LY294002, and NVP-BEZ235

Fernandes, H. R., Gomes, G. F., de Oliveira, A. C. P., & Campos, S. (2023) · Science of Computer Programming · doi:10.1016/j.scico.2023.103028 · Cited by 1

(−)‐Epicatechin Rescues Memory Deficits by Activation of Autophagy in a Mouse Model of Tauopathies

Wu, Y., Li, T., Jiang, X., Ling, J., Zhao, Z., Zhu, J., Chen, C., Liu, Q., Yang, X., Shen, X., et al. (2025) · MedComm · doi:10.1002/mco2.70144 · Cited by 2

Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy

Schaeffer, V., Lavenir, I., Ozcelik, S., Tolnay, M., Winkler, D. T., & Goedert, M. (2012) · Brain · doi:10.1093/brain/aws143 · Cited by 343

Mechanisms of tau fragmentation, aggregation and degradation in transgenic mouse models

Özcelik, S. (2013) · edoc (University of Basel) · doi:10.5451/unibas-006230970

Rapamycin Ester Analog CCI-779/Temsirolimus Alleviates Tau Pathology and Improves Motor Deficit in Mutant Tau Transgenic Mice

Frédérick, C., Ando, K., Leroy, K., Héraud, C., Suain, V., Buée, L., & Brion, J. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142097 · Cited by 69

Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits

Majumder, S., Richardson, A., Strong, R., & Oddo, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025416 · Cited by 365

Rapamycin Delays Disease Onset and Prevents PrP Plaque Deposition in a Mouse Model of Gerstmann–Sträussler–Scheinker Disease

Cortés, C. J., Qin, K., Cook, J., Solanki, A., & Mastrianni, J. A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6189-11.2012 · Cited by 113